Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
20.65
+1.16 (5.95%)
At close: Nov 3, 2026, 4:00 PM EST
20.38
-0.27 (-1.32%)
After-hours: Nov 3, 2026, 7:54 PM EST
Replimune Group Employees
Replimune Group had 465 employees as of March 31, 2026. The number of employees decreased by 14 or 2.92% compared to the previous year. That makes Replimune Group the 20,627th largest employer in the world and 2,746th in the United States.
Employees
465
Change (1Y)
-14
Growth (1Y)
-2.92%
Revenue / Employee
n/a
Profits / Employee
-$582,869
Market Cap
1.96B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 465 | -14 | -2.92% |
| Mar 31, 2025 | 479 | 148 | 44.71% |
| Mar 31, 2024 | 331 | 47 | 16.55% |
| Mar 31, 2023 | 284 | 78 | 37.86% |
| Mar 31, 2022 | 206 | 54 | 35.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| Agios Pharmaceuticals | 540 |
| Maravai LifeSciences Holdings | 415 |
| Vir Biotechnology | 367 |
| Precigen | 160 |
| Septerna | 123 |
| Mesoblast | 108 |
REPL News
- 5 days ago - Replimune price target raised to $31 from $19 at Leerink - TheFly
- 6 days ago - Replimune price target raised to $29 from $24 at Jefferies - TheFly
- 6 days ago - Replimune Group Earnings Call Transcript: Q2 2027 - Transcripts
- 6 days ago - Replimune Group Earnings release: Q2 2027 - Filings
- 6 days ago - Replimune Group Quarterly report: Q2 2027 - Filings
- 6 days ago - Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update - GlobeNewsWire
- 12 days ago - Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026 - GlobeNewsWire
- 4 weeks ago - Replimune announces Tudriqev now available in U.S. for advanced melanoma - TheFly